Focusing the neuroscience and societal implications of cognitive enhancers

G. Savulich; T. Piercy; A. B. Brühl; C. Fox; J. Suckling; J. B. Rowe; J. T. O'Brien; B. J. Sahakian

doi:10.1002/cpt.457

Focusing the neuroscience and societal implications of cognitive enhancers

G. Savulich, T. Piercy, A. B. Brühl, C. Fox, J. Suckling, J. B. Rowe, J. T. O'Brien, B. J. Sahakian

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

7 Downloads (Pure)

Abstract

Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Non-pharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of ‘smart’ and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.

Original language	English
Pages (from-to)	170–172
Number of pages	3
Journal	Clinical Pharmacology and Therapeutics
Volume	101
Issue number	2
Early online date	23 Sep 2016
DOIs	https://doi.org/10.1002/cpt.457
Publication status	Published - Feb 2017

Access to Document

10.1002/cpt.457

Accepted manuscriptAccepted author manuscript, 968 KB

Chris Fox
- Chris.Foxuea.acuk
- Norwich Medical School - Honorary Professor
- Institute for Volunteering Research - Member
- Norwich Epidemiology Centre - Member
- Mental Health - Member
Person: Honorary, Research Group Member, Research Centre Member

Cite this

@article{8fa1f0f3d05f4662969d83745d7a48a2,

title = "Focusing the neuroscience and societal implications of cognitive enhancers",

abstract = "Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Non-pharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of {\textquoteleft}smart{\textquoteright} and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.",

author = "G. Savulich and T. Piercy and Br{\"u}hl, {A. B.} and C. Fox and J. Suckling and Rowe, {J. B.} and O'Brien, {J. T.} and Sahakian, {B. J.}",

year = "2017",

month = feb,

doi = "10.1002/cpt.457",

language = "English",

volume = "101",

pages = "170–172",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Focusing the neuroscience and societal implications of cognitive enhancers

AU - Savulich, G.

AU - Piercy, T.

AU - Brühl, A. B.

AU - Fox, C.

AU - Suckling, J.

AU - Rowe, J. B.

AU - O'Brien, J. T.

AU - Sahakian, B. J.

PY - 2017/2

Y1 - 2017/2

N2 - Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Non-pharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of ‘smart’ and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.

AB - Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Non-pharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of ‘smart’ and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.

U2 - 10.1002/cpt.457

DO - 10.1002/cpt.457

M3 - Article

VL - 101

SP - 170

EP - 172

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -

Focusing the neuroscience and societal implications of cognitive enhancers

Abstract

Access to Document

Profiles

Chris Fox

Cite this